In the latest session, Aspen Aerogels Inc. (NYSE: ASPN) closed at $16.34 down -3.83% from its previous closing price of $16.99. In other words, the price has decreased by -$0.65 from its previous closing price. On the day, 1053516 shares were traded.
Ratios:
For a deeper understanding of Aspen Aerogels Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.91 and its Current Ratio is at 3.41. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.28.
On December 10, 2021, The Benchmark Company started tracking the stock assigning a Buy rating and target price of $70.The Benchmark Company initiated its Buy rating on December 10, 2021, with a $70 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 20 when Landes Gregg sold 155 shares for $11.01 per share. The transaction valued at 1,707 led to the insider holds 126,393 shares of the business.
Mitchell Steven R bought 7,541 shares of ASPN for $49,009 on Sep 07. The Director now owns 134,260 shares after completing the transaction at $6.50 per share. On Sep 05, another insider, Mitchell Steven R, who serves as the Director of the company, bought 50,000 shares for $6.17 each. As a result, the insider paid 308,455 and bolstered with 126,719 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASPN now has a Market Capitalization of 1.25B and an Enterprise Value of 1.25B. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.22 while its Price-to-Book (P/B) ratio in mrq is 2.80. Its current Enterprise Value per Revenue stands at 5.22 whereas that against EBITDA is -30.78.
Stock Price History:
Over the past 52 weeks, ASPN has reached a high of $18.72, while it has fallen to a 52-week low of $5.32. The 50-Day Moving Average of the stock is 14.24, while the 200-Day Moving Average is calculated to be 9.64.
Shares Statistics:
For the past three months, ASPN has traded an average of 1.12M shares per day and 1.17M over the past ten days. A total of 76.32M shares are outstanding, with a floating share count of 74.33M. Insiders hold about 2.60% of the company’s shares, while institutions hold 98.59% stake in the company. Shares short for ASPN as of Feb 15, 2024 were 4.65M with a Short Ratio of 4.15, compared to 4.67M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.09% and a Short% of Float of 8.09%.
Earnings Estimates
There are 8 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.02 and a low estimate of -$0.17, while EPS last year was -$0.24. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.02 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.08 and -$0.31 for the fiscal current year, implying an average EPS of -$0.21. EPS for the following year is $0.69, with 7 analysts recommending between $1.36 and $0.3.
Revenue Estimates
A total of 8 analysts believe the company’s revenue will be $75.69M this quarter.It ranges from a high estimate of $87.5M to a low estimate of $58.66M. As of the current estimate, Aspen Aerogels Inc.’s year-ago sales were $45.14M, an estimated increase of 67.70% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $85.4M, an increase of 77.30% over than the figure of $67.70% in the same quarter last year. There is a high estimate of $91.39M for the next quarter, whereas the lowest estimate is $82M.
A total of 8 analysts have provided revenue estimates for ASPN’s current fiscal year. The highest revenue estimate was $403.41M, while the lowest revenue estimate was $348.94M, resulting in an average revenue estimate of $363.52M. In the same quarter a year ago, actual revenue was $238.72M, up 52.30% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $579.8M in the next fiscal year. The high estimate is $674.74M and the low estimate is $513M. The average revenue growth estimate for next year is up 59.50% from the average revenue estimate for this year.
